PARTNER AT FANGDA PARTNERS
Mr. Josh Shin specializes in M&A, general corporate advices, private equity investment, and overseas capital markets, with a strong track record in various legal issues in the pharmaceutical, life science and healthcare sectors.
Mr. Shin leads the healthcare practice of the firm’s corporate group. His experience in the sector includes major transactions in the sub-areas of pharmaceuticals, medical devices and medical services, as well as regularly offering advice to clients on regulatory
developments in issues at the forefront of this area of law.
Josh’s recent experience in the healthcare area includes proposed acquisition by private equity fund of Cardinal Health’s China business, Bayer’s acquisition of Dihon Pharmaceuticals, Wuxi AppTec’s joint venture with Mayo Clinics, exclusive commercialization/ licensing arrangement of a number of drugs owned by big pharma, and the overseas IPO of a number of biotech companies.
Mr. Shin is nominated as recognized practitioner for Healthcare by Chambers Asia Pacific 2019.